CD274 and ocular melanoma: We further show here that PD-L1 is a critical mediator of OM-MOG tolerance because the administration of a neutralizing anti-PD-L1 antibody totally abrogated the therapeutic effects of OM-MOG, while mice with DC-specific deletion of PD-L1 maintained full protection by therapeutic OM-MOG.